Peginterferon for chronic hepatitis B: Predicting success with on-treatment benchmarks

被引：7
作者：
Moucari, Rami [1 ,2 ]
机构：
[1] Hop Beaujon, Serv Hepatol, F-92110 Clichy, France
[2] Hop Beaujon, INSERM, U773, F-92110 Clichy, France
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2010年 / 25卷 / 09期
关键词：
SUSTAINED HBEAG; SERUM HBSAG; INTERFERON; SEROCONVERSION; SUPPRESSION; ALPHA-2A; THERAPY;
D O I：
10.1111/j.1440-1746.2010.06372.x
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1474 / 1475
页数：2
相关论文
共 50 条
  • [31] Pharmacoeconomic analysis of the treatment of chronic hepatitis C with peginterferon alfa-2a or peginterferon alfa-2b plus ribavirin in Spain
    Turnes, Juan
    Romero-Gomez, Manuel
    Planas, Ramon
    Sola, Ricard
    Garcia-Samaniego, Javier
    Diago, Moises
    Crespo, Javier
    Calleja, Jose Luis
    Rubio-Terres, Carlos
    Ventayol, Pere
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2013, 36 (09): : 555 - 564
  • [32] Treatment with peginterferon versus interferon in Chinese patients with chronic hepatitis C
    Zhao, S.
    Liu, E.
    Wei, K.
    Wang, Y.
    Li, Y.
    Huang, B.
    Chen, Y.
    Yang, P.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2011, 30 (01) : 51 - 57
  • [33] Treatment with peginterferon versus interferon in Chinese patients with chronic hepatitis C
    S. Zhao
    E. Liu
    K. Wei
    Y. Wang
    Y. Li
    B. Huang
    Y. Chen
    P. Yang
    European Journal of Clinical Microbiology & Infectious Diseases, 2011, 30 : 51 - 57
  • [34] Results of treatment with peginterferon plus ribavirin in patients with chronic hepatitis C
    Pizarro, Carolina
    Venegas, Mauricio
    Hola, Karen
    Smok, Gladys
    Brahm, Javier
    REVISTA MEDICA DE CHILE, 2011, 139 (06) : 704 - 709
  • [35] Treatment of chronic hepatitis B
    Marcellin, P
    Asselah, T
    Boyer, N
    JOURNAL OF VIRAL HEPATITIS, 2005, 12 (04) : 333 - 345
  • [36] Presence of precore and core promoter mutants limits the probability of response to peginterferon in hepatitis B e antigen-positive chronic hepatitis B
    Sonneveld, Milan J.
    Rijckborst, Vincent
    Zeuzem, Stefan
    Heathcote, E. Jenny
    Simon, Krzysztof
    Senturk, Hakan
    Pas, Suzan D.
    Hansen, Bettina E.
    Janssen, Harry L. A.
    HEPATOLOGY, 2012, 56 (01) : 67 - 75
  • [37] Treatment of chronic hepatitis B
    Mohanty, Smruti R.
    Kupfer, Sonia S.
    Khiani, Vijay
    NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2006, 3 (08): : 446 - 458
  • [38] Peginterferon alfa-2b in the treatment of Chinese patients with HBeAg-positive chronic hepatitis B: A randomized trial
    Cheng, Jun
    Wang, Yuming
    Hou, Jinlin
    Luo, Duande
    Xie, Qing
    Ning, Qin
    Ren, Hong
    Ding, Huiguo
    Sheng, Jifang
    Wei, Lai
    Chen, Shijun
    Fan, Xiaoling
    Huang, Wenxiang
    Pan, Chen
    Gao, Zhiliang
    Zhang, Jiming
    Zhou, Boping
    Chen, Guofeng
    Wan, Mobin
    Tang, Hong
    Wang, Guiqiang
    Yang, Yuxiu
    Mohamed, Rosmawati
    Guan, Richard
    Lee, Tzong-Hsi
    Chang, Wen-Hsiung
    Huang Zhenfei
    Ye, Zhang
    Xu, Daozhen
    JOURNAL OF CLINICAL VIROLOGY, 2014, 61 (04) : 509 - 516
  • [39] Randomized Trial of Tenofovir With or Without Peginterferon Alfa Followed by Protocolized Treatment Withdrawal in Adults With Chronic Hepatitis B
    Terrault, Norah S.
    Lok, Anna S.
    Wahed, Abdus G.
    Ghany, Marc P.
    Perrillo, Robert W.
    Fried, Michael K.
    Wong, David K.
    Khalili, Mandana
    Lau, Daryl T. Y. K.
    Sterling, Richard M.
    Di Bisceglie, Adrian
    Lisker-Melman, Mauricio L.
    Cooper, Stewart T.
    Chung, Ray T.
    Patel, Keyur R.
    Roberts, Lewis H.
    Belle, Steven
    Janssen, Harry L. A.
    Hepatitis B Res Network
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (07) : 1214 - 1225
  • [40] Clinical Predictors for Neutrophil-to-Lymphocyte Ratio Changes in Patients with Chronic Hepatitis B Receiving Peginterferon Treatment
    Le, Puo-Hsien
    Liang, Kung-Hao
    Chang, Ming-Ling
    Hsu, Chao-Wei
    Chen, Yi-Cheng
    Lin, Chih-Lang
    Lin, Wey-Ran
    Lai, Ming-Wei
    Yeh, Chau-Ting
    IN VIVO, 2017, 31 (04): : 723 - 729
12345